Text Size
28 studies found for:    " June 06, 2007":" July 06, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
" June 06, 2007":" July 06, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Growth Hormone in the Treatment of HIV-Associated Wasting
Conditions: HIV Infections;   HIV Wasting Syndrome
Intervention: Drug: Somatropin; Recombinant human growth hormone (r hGH)
2 Completed
Has Results 		Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir
Condition: HIV Infections
Intervention: Drug: Buprenorphine, Tipranavir and ritonavir
3 Completed Microbicides Acceptability Among Sexually Active Young Women
Condition: HIV Infections
Intervention: Behavioral: Automated diary system
4 Completed Aripiprazole Treatment for Methamphetamine Dependence Among High-risk Individuals
Conditions: Substance Abuse;   HIV Infections
Intervention: Drug: aripiprazole
5 Completed Mirtazapine to Reduce Methamphetamine Use Among MSM With High-risk HIV Behaviors
Conditions: Substance Abuse;   HIV Infections
Intervention: Drug: mirtazapine
6 Unknown † Effects of HIV and Hepatitis C Virus on the Brain
Conditions: HIV Infections;   Hepatitis C
Intervention:
7 Unknown † HIV Prevention in Haitian American Adolescents
Condition: HIV Infections
Intervention: Behavioral: Cognitive Behavioral and Standard Care with Healthy Living
8 Unknown † HIV Prevention for Youth With Severe Mental Illness
Condition: HIV Infections
Intervention: Behavioral: Family-based HIV prevention program
9 Suspended Expanded Characterization of Immune Response to Merck Adenovirus 5 Gag/Pol/Nef Vaccine Given to HIV Uninfected Adults
Condition: HIV Infections
Intervention: Biological: MRKAd5 HIV-1 gag/pol/nef
10 Withdrawn Safety and Effectiveness of an HIV DNA Vaccine Followed by an HIV Adenoviral Vector Vaccine for Prevention of HIV Infection in the Americas and Africa
Condition: HIV Infections
Interventions: Biological: VRC-HIVDNA016-00-VP;   Biological: VRC-HIVADV014-00-VP;   Biological: VRC-HIVDNA016-00-VP placebo;   Biological: VRC-HIVADV014-00-VP placebo
11 Completed Study to Compare the Immunogenicity and Safety of Two HIV Preventive Vaccinations in Healthy Volunteers
Condition: HIV Infections
Interventions: Biological: DNA-C;   Biological: NYVAC-C
12 Completed ProAlgaZyme Novel Algae Infusion: Applications in Immunodeficiency
Conditions: HIV Infections;   Hepatitis B;   Dyslipidemia
Intervention: Drug: ProAlgaZyme
13 Completed Management of Hepatitis C in HIV-Infected and Uninfected IDUs
Conditions: Hepatitis C Virus;   HIV Infections
Intervention: Drug: Peginterferon/Ribavirin
14 Completed Effects of Creatine and Resistance Exercise Training in People With HIV Infection
Condition: HIV Infections
Interventions: Procedure: Use of creatine monohydrate (a dietary supplement);   Behavioral: Progressive resistance exercise training
15 Unknown † Engaging Care for HIV-Infected Adolescent Females.
Condition: HIV Infection
Intervention:
16 Active, not recruiting Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO)
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Antiretroviral medications;   Drug: Antiretroviral medications+Isoniazid prophylaxis
17 Completed Project HERMITAGE: HIV Prevention in Hospitalized Russian Drinkers
Condition: HIV Infections
Interventions: Behavioral: Individual and group HIV risk behavior counseling sessions;   Behavioral: health education and support group
18 Completed HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of Biomarkers
Conditions: HIV Infections;   AIDS;   Lung Cancer;   Tobacco Addiction;   Drug Addiction
Intervention:
19 Completed An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals
Conditions: HIV Infections;   HCV
Interventions: Drug: Albinterferon;   Drug: Ribavirin;   Drug: Albuferon
20 Withdrawn Safety And Efficacy Study Of CP-675,206 In HIV-Infected Patients
Condition: Human Immunodeficiency Virus
Intervention: Drug: CP-675,206
To Top

Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results
† Indicates status has not been verified in more than two years